EVENT IS SOLD OUT---The brave (and economical) new world of medtech innovation-Paul Yock, M.D.-04/09/2013 - 6:00pm

Event Information
Event Topic: 
EVENT IS SOLD OUT---The brave (and economical) new world of medtech innovation
Event Date: 
04/09/2013 - 6:00pm
Event Location: 
Wilson Sonsini Goodrich & Rosati, 650 Page Mill Road, Palo Alto CA
Speaker Information
Event Speaker: 
Paul Yock, M.D.
Event Speaker Title: 
Martha Meier Weiland Prof. of Medicine & ME, and Founding Co-Chair of Bioengineering
Event Speaker Company: 
Stanford University
Event Speaker Bio: 

Paul Yock, M.D.

Paul Yock is the Martha Meier Weiland Professor of Medicine and Mechanical Engineering (by courtesy) and Founding Co-Chair of Stanford’s new Department of Bioengineering. He also holds a courtesy appointment on Operations, Information and Technology in the Stanford School of Business.
Dr. Yock is internationally known for his work in inventing, developing and testing new devices, including the Rapid Exchange ™ balloon angioplasty system, which is now the primary system in use worldwide. He also invented a Doppler-guided access system known as the Smart Needle™ and PD-Access™. The main focus of Dr. Yock’s research program has been in the field of intravascular ultrasound. He authored the fundamental patents for mechanical intravascular ultrasound imaging and helped conduct the initial clinical trials. In 1986 he founded Cardiovascular Imaging Systems, which was acquired by Boston Scientific in 1994. Dr. Yock has cofounded several other medical technology companies.
In his academic career, Dr. Yock has authored over 300 peer-reviewed publications, chapters and editorials, a textbook and over 45 US patents. Recent awards include the Transcatheter Therapeutics (TCT) Career Achievement Award, the American College of Cardiology Distinguished Scientist Award and an honorary doctorate from Amherst College. Dr. Yock is a member of the National Academy of Engineering. Current research interests of Dr. Yock’s group at Stanford focus on development and testing of catheter-based delivery systems for cardiac cell transplantation and new catheter and molecular imaging techniques for cardiology. Dr. Yock also founded and directs the Program in Biodesign, a unit of Stanford’s Bio-X initiative that focuses on invention and technology transfer related to biomedical engineering.

Event Details
Event Details: 

We are in the early stages of an historic shift in medical technology innovation in which global developing economies will play a critical role. The markets for medical technologies are expanding much more rapidly in the BRIC countries than in the West, particularly China and India. The dynamics of these markets are spawning new technologies with a lower cost profile than in the U.S. or Europe. At the same time, in America we have entered a perfect storm for medical technology innovation as we have known it, with increased regulatory barriers, uncertain reimbursement reform and diminished venture funding. One positive outcome for America is the potential for a virtuous cycle of low-cost innovation, where more affordable technologies developed for markets abroad will enter the U.S. market—and, in turn, will help force a new emphasis on affordability for products developed here.